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Abstract
Medullary carcinoma of the thyroid (MTC) commonly spreads through the lymphatics to distant sites such as lung, liver and 
bone. Spread to the breast is rare. We report a case of metastatic MTC which progressed to develop nodal metastases to cer-
vical and mediastinal regions, visceral metastases to the liver, lung and ultimately to bilateral breasts. Clinically it is important 
to distinguish metastatic breast lesions from primary breast cancer as each is managed differently. Both cytological and radio-
logical investigations were done followed by excision biopsy. Histopathological examination of post excision breast specimen 
revealed metastatic medullary carcinoma, with positive immunohistochemical staining for calcitonin. A brief review of literature 
and differential diagnosis is also presented.
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Introduction
Medullary carcinoma of the thyroid (MTC) originates from the 
parafollicular C-cells and accounts for 3–4% of all malignant thyroid 
neoplasms. It occurs sporadically (75% of cases) or as part of the 
inherited syndrome known as multiple endocrine neoplasia type 2 
(MEN II syndrome) [1]. Currently, there is no effective treatment for 
patients with locally advanced or metastatic disease as this tumor 
is usually unresponsive to conventional chemotherapy or radiother-
apy. Typically MTC metastasizes through lymphatics to mediastinal 
lymph nodes, lung, liver and bone.
Case report
A 20-year-old female presented to our cancer center with history 
of left lobectomy and neck nodal dissection in April 2006. Referred 
sections were reviewed by histopathology department and revealed 
a thyroid tumor consistent with medullary carcinoma thyroid (Figure 1). 
 She was diagnosed as T2N1bM0 stage II medullary carcinoma 
of thyroid. Baseline work up for MEN II syndrome was unremark-
able. Her baseline I-131 MIBG scan at a serum Calcitonin level of 
1829 pg/ml was unremarkable (not shown). Completion thyroidec-
tomy was done. Her postoperative serum calcitonin level dropped 
to 393 pg/ml in March 2007 followed by 676 pg/ml in June 2007. 
In January 2008, HYNIC octreotide scan (Figure 2) performed at 
4 and 24 hours demonstrated an avid lesion in proximal shaft of 
right humerus and upper part of the chest. Bone scan (Figure 3) 
performed in January 2008 also showed a linear increased tracer 
uptake in proximal part of the right humeral shaft correlating with 
the increased uptake seen on HYNIC-Octreotide scan. In addition 
increased uptake was seen in mid thoracic spine, right acetabulum 
and iliac wing. Patient received radiation therapy for right upper 
humeral head lesion in February 2008.
On follow up, post radiotherapy calcitonin levels once again 
began to rise – 1500 pg/ml in September 2008. Anterior/posterior 
Figure 1A. High power view of thyroid show a cellular neoplasm. 
Monomorphic plasmacytoid cells with salt and pepper chromatin 
and eosinophilic material (amyloid) in tumor cells; B Calcitonin 
immunohistochemistry: positive cytoplasmic staining in thyroid tumor 
cells
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spot view and SPECT images of the thorax using HYNIC Octreo-
tide (Figure 4) showed a new focus of uptake in the mediastinum 
as well as mild focal uptake in bilateral breasts. Uptake in the 
humerus was less intense as compared with the previous scan.
Contrast enhanced CT (CeCT) images (Figure 5) in September 
2008 also showed disease progression with calcified cervical and 
mediastinal nodes. However, patient was asymptomatic at that time. 
She remained asymptomatic and serum calcitonin progressively 
Figure 2. HYNIC octreotide scan demonstrated an avid lesion  
in proximal shaft of right humerus and upper part of the chest
Figure 3. Bone scan showed linear increase in tracer uptake  
in proximal part of the right humeral shaft, mid thoracic spine,  
right acetabulum and iliac wing
Figure 5A, B. Axial CT images showing (A) right supraclavicular necrotic lymph node (B) right hilar nodule
Figure 4. HYNIC Octreotide scan showed a new focus of uptake in the mediastinum as well as mild focal uptake  
in bilateral breasts. Uptake in the humerus was less intense compared with the previous scan
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increased to 16521 pg/ml in September 2012. She developed pal-
pable nodules in bilateral breasts.CeCT (Figure 6) performed at the 
same time showed progressive disease with hepatic, osseous and 
mediastinal nodal metastasis.
Tru-cut biopsy of breast nodules was performed. Microscopic 
features (Figure 7) revealed infiltrative and cellular tumor composed 
of plasmacytoid cells with round nuclei, salt and pepper chromatin 
and eosinophilic material were present within the tumor clusters. 
Desmoplastic stroma was also present.
Discussion
Carcinoma of thyroid metastatic to breast is extremely rare. 
Metastatic tumors to breast account for 0.8 to 6.6% of all breast 
malignancies [2]. Very few cases have been reported in literature 
and to our knowledge only 6 cases were classified as secondary 
metastasis from medullary Carcinoma thyroid [3–8]. Medullary car-
cinoma of thyroid commonly metastasizes to cervical lymph nodes, 
liver, lung and bones. Calcifications are frequently seen in cervical 
lymph nodes and liver [3]. Metastatic carcinoma to the breast arises, 
in most cases, secondary to primary breast malignancy on the other 
side particularly in females as opposed to hematopoietic malignan-
cies (leukemia, lymphoma) and prostate carcinoma in males, which 
are common metastatic tumors to male breast [2, 4]. Accurate 
diagnosis of secondaries to breast is important to avoid unneces-
sary radical surgical procedures and to institute appropriate therapy. 
There are no reliable clinical criteria to distinguish primary breast 
tumors from secondary metastasis. However, on literature review, 
a superficial sharply circumscribed lesion in upper outer quadrant 
of breast with skin tethering or multiple superficial hard nodular 
masses should raise the concern of secondary tumor, especially if 
the patient is suffering from known malignancy [4, 9, 10]. Ultimate 
diagnosis is based on histologic features. Histological features sug-
gestive of metastatic disease include a periductal or perilobular 
distribution in the absence of in situ ductal or lobular component. 
There is minimal elastosis and desmoplasia associated with these 
lesions. Final confirmation usually requires immune-histochemical 
staining to establish the diagnosis [4, 6, 11].
Most of the metastatic tumors in breast have predilection for 
younger or middle aged women, likely due to better blood supply 
in this age group that leads to blood-borne metastasis [11, 12]. 
Overall prognosis of such cases is usually grave with approximately 
90% of the patients dying within a year of diagnosis [13].
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Figure 6A. Axial CT image show a representative metastatic liver lesion; 
B. Axial CT image show enhancing bilateral breast nodules and interval 
progression in mediastinal nodes (previous CT not shown);  
C. Sagittal CT image show sclerotic osseous metastases
Figure 7A. H&E of breast tru-cut biopsy show an infiltrative  
and cellular tumor of plasmacytoid cells with round nuclei,  
salt and pepper chromatin and eosinophilic material in tumor cells;  
B. Calcitonin immunohistochemistry: positive staining in tumor cells
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